Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
Japan's Atsushi Mimura asserts that the IMF's floating rate label won't stop currency intervention. Traders must now account for higher tactical flexibility.
The Rupee's 67 paise surge creates immediate margin pressure for IT exporters and shifts the outlook for financial stocks. Monitor liquidity for a reversal.
Lunnon Metals reports high-grade gold hits at Paringa West, including 14m at 2.62 g/t, as it prepares for critical September assay results.
Lantronix targets $10M-$14M in drone revenue for FY2026, aiming for a 15%-20% mix by FY2027. Watch for quarterly execution against these specific benchmarks.
AI-driven litigation is forcing insurers to determine if algorithmic risks are insurable, creating a new financial hurdle for companies deploying AI systems.
Bittrex is petitioning a federal court to reclaim $24 million from the SEC, arguing that the agency's shift in crypto policy invalidates past settlements.
Compass Diversified projects $320M-$365M in 2026 subsidiary EBITDA. The firm is prioritizing debt reduction over expansion to improve its balance sheet health.
With the U.S. debt-to-GDP ratio hitting 100.2%, investors are shifting toward real assets to hedge against the potential for long-term currency devaluation.
L&T aims to double revenue to ₹5.8 trillion by FY31 under its new Lakshya 31 plan, shifting capital toward green hydrogen and semiconductor manufacturing.
Original ChopShop is leveraging a new seasonal protein shake and an in-app loyalty punch card to drive digital engagement through August 3. The campaign aims to
Aurum Resources reports thick gold intercepts at BDT2, expanding its 3.03M ounce Boundiali project. With $61M in cash, the firm targets a 2026 feasibility study.
Robinhood has secured 150,000 investors for its private markets fund, which includes a $75M stake in OpenAI. The vehicle offers daily liquidity and no carry.
Anthropic's Boris Cherny is moving the AI coding narrative toward technical rigor. The shift from vibe coding to deterministic output impacts sector valuations.
Milken Conference ticket costs reach $75,000, forcing firms like Blue Owl to prioritize off-site networking to capture institutional capital and allocations.
Marex Q1 2026 results highlight a strategic shift toward fee-based income as volume-driven clearing activity remains the firm's primary growth engine.
Recursion Pharmaceuticals shifts to a high-conviction AI drug discovery model in Q1 2026, prioritizing capital discipline and clinical proof points.
Guardian Pharmacy Services (GRDN) navigates PBM reimbursement headwinds in Q1 2026. Growth hinges on facility occupancy and disciplined pharmacy acquisitions.
Legislative progress on the EU-US trade deal remains stalled, with the May 19 Strasbourg trilogue now the critical date for resolving tariff uncertainty.
Mineros reported record Q1 2026 revenue of $291.8M and adjusted EBITDA of $154.1M. The company now holds 31,623 ounces of gold-backed assets in its treasury.
PwC and OpenAI are building AI-native finance agents to handle procurement, forecasting, and tax compliance, shifting finance roles toward oversight.
Quanterix targets $169M-$174M in 2026 revenue as it prepares for a 2027 HD-X IVD filing. The clinical diagnostic transition remains the primary valuation driver.
UTI maintains its $905M-$915M revenue target for FY2026. Success now hinges on the enrollment ramp-up speed at new campuses to protect margins and EPS.
Chime achieved its first GAAP-profitable quarter with 25% revenue growth and 10.2 million active members. AI-assisted coding now drives 84% of internal output.
Airgain projects Q2 revenue between $12.5M and $14.5M with a $0.01 EPS midpoint. Success hinges on the MegaFi 2 integration and the timing of the Lighthouse project.
J&J Snack Foods aims for $20M in annual savings by Q4 via its Apollo program to counter fuel-driven demand softness. Watch for margin impacts in upcoming results.
Cirrus Logic guides for $430M-$490M in Q1 revenue while signaling higher R&D spending. The shift in capital allocation creates a new test for margin stability.
Niagen Bioscience reaffirms its 10%-15% growth target for 2026, but rising marketing costs and Amazon-related headwinds create new margin pressure for NAGE.
Vermilion Energy pivots to capital discipline in 2026, prioritizing balance sheet stability over growth. Track the impact on VET and the broader energy sector.
IAMGOLD's Q1 2026 results center on operational stability and capital discipline. Monitor production costs and project milestones for future valuation shifts.
A key House committee begins crypto bill markup next week. Watch for ethics provisions and macro-driven volatility as BTC exchange inflows hit $262 million.